2023-06-012024-05-312024-05-31false08063677Lords Healthcare Ltd2025-01-1382990falseiso4217:GBPxbrli:pure080636772023-06-01080636772024-05-31080636772023-06-012024-05-31080636772022-06-01080636772023-05-31080636772022-06-012023-05-3108063677bus:SmallEntities2023-06-012024-05-3108063677bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3108063677bus:FullAccounts2023-06-012024-05-3108063677bus:PrivateLimitedCompanyLtd2023-06-012024-05-3108063677core:WithinOneYear2024-05-3108063677core:AfterOneYear2024-05-3108063677core:WithinOneYear2023-05-3108063677core:AfterOneYear2023-05-3108063677core:ShareCapital2024-05-3108063677core:SharePremium2024-05-3108063677core:RevaluationReserve2024-05-3108063677core:OtherReservesSubtotal2024-05-3108063677core:RetainedEarningsAccumulatedLosses2024-05-3108063677core:ShareCapital2023-05-3108063677core:SharePremium2023-05-3108063677core:RevaluationReserve2023-05-3108063677core:OtherReservesSubtotal2023-05-3108063677core:RetainedEarningsAccumulatedLosses2023-05-3108063677core:LandBuildings2024-05-3108063677core:PlantMachinery2024-05-3108063677core:Vehicles2024-05-3108063677core:FurnitureFittings2024-05-3108063677core:OfficeEquipment2024-05-3108063677core:NetGoodwill2024-05-3108063677core:IntangibleAssetsOtherThanGoodwill2024-05-3108063677core:ListedExchangeTraded2024-05-3108063677core:UnlistedNon-exchangeTraded2024-05-3108063677core:LandBuildings2023-05-3108063677core:PlantMachinery2023-05-3108063677core:Vehicles2023-05-3108063677core:FurnitureFittings2023-05-3108063677core:OfficeEquipment2023-05-3108063677core:NetGoodwill2023-05-3108063677core:IntangibleAssetsOtherThanGoodwill2023-05-3108063677core:ListedExchangeTraded2023-05-3108063677core:UnlistedNon-exchangeTraded2023-05-3108063677core:LandBuildings2023-06-012024-05-3108063677core:PlantMachinery2023-06-012024-05-3108063677core:Vehicles2023-06-012024-05-3108063677core:FurnitureFittings2023-06-012024-05-3108063677core:OfficeEquipment2023-06-012024-05-3108063677core:NetGoodwill2023-06-012024-05-3108063677core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3108063677core:ListedExchangeTraded2023-06-012024-05-3108063677core:UnlistedNon-exchangeTraded2023-06-012024-05-3108063677core:MoreThanFiveYears2023-06-012024-05-3108063677core:Non-currentFinancialInstruments2024-05-3108063677core:Non-currentFinancialInstruments2023-05-3108063677dpl:CostSales2023-06-012024-05-3108063677dpl:DistributionCosts2023-06-012024-05-3108063677core:LandBuildings2023-06-012024-05-3108063677core:PlantMachinery2023-06-012024-05-3108063677core:Vehicles2023-06-012024-05-3108063677core:FurnitureFittings2023-06-012024-05-3108063677core:OfficeEquipment2023-06-012024-05-3108063677dpl:AdministrativeExpenses2023-06-012024-05-3108063677core:NetGoodwill2023-06-012024-05-3108063677core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3108063677dpl:GroupUndertakings2023-06-012024-05-3108063677dpl:ParticipatingInterests2023-06-012024-05-3108063677dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3108063677core:ListedExchangeTraded2023-06-012024-05-3108063677dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3108063677core:UnlistedNon-exchangeTraded2023-06-012024-05-3108063677dpl:CostSales2022-06-012023-05-3108063677dpl:DistributionCosts2022-06-012023-05-3108063677core:LandBuildings2022-06-012023-05-3108063677core:PlantMachinery2022-06-012023-05-3108063677core:Vehicles2022-06-012023-05-3108063677core:FurnitureFittings2022-06-012023-05-3108063677core:OfficeEquipment2022-06-012023-05-3108063677dpl:AdministrativeExpenses2022-06-012023-05-3108063677core:NetGoodwill2022-06-012023-05-3108063677core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3108063677dpl:GroupUndertakings2022-06-012023-05-3108063677dpl:ParticipatingInterests2022-06-012023-05-3108063677dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3108063677core:ListedExchangeTraded2022-06-012023-05-3108063677dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3108063677core:UnlistedNon-exchangeTraded2022-06-012023-05-3108063677core:NetGoodwill2024-05-3108063677core:IntangibleAssetsOtherThanGoodwill2024-05-3108063677core:LandBuildings2024-05-3108063677core:PlantMachinery2024-05-3108063677core:Vehicles2024-05-3108063677core:FurnitureFittings2024-05-3108063677core:OfficeEquipment2024-05-3108063677core:AfterOneYear2024-05-3108063677core:WithinOneYear2024-05-3108063677core:ListedExchangeTraded2024-05-3108063677core:UnlistedNon-exchangeTraded2024-05-3108063677core:ShareCapital2024-05-3108063677core:SharePremium2024-05-3108063677core:RevaluationReserve2024-05-3108063677core:OtherReservesSubtotal2024-05-3108063677core:RetainedEarningsAccumulatedLosses2024-05-3108063677core:NetGoodwill2023-05-3108063677core:IntangibleAssetsOtherThanGoodwill2023-05-3108063677core:LandBuildings2023-05-3108063677core:PlantMachinery2023-05-3108063677core:Vehicles2023-05-3108063677core:FurnitureFittings2023-05-3108063677core:OfficeEquipment2023-05-3108063677core:AfterOneYear2023-05-3108063677core:WithinOneYear2023-05-3108063677core:ListedExchangeTraded2023-05-3108063677core:UnlistedNon-exchangeTraded2023-05-3108063677core:ShareCapital2023-05-3108063677core:SharePremium2023-05-3108063677core:RevaluationReserve2023-05-3108063677core:OtherReservesSubtotal2023-05-3108063677core:RetainedEarningsAccumulatedLosses2023-05-3108063677core:NetGoodwill2022-06-0108063677core:IntangibleAssetsOtherThanGoodwill2022-06-0108063677core:LandBuildings2022-06-0108063677core:PlantMachinery2022-06-0108063677core:Vehicles2022-06-0108063677core:FurnitureFittings2022-06-0108063677core:OfficeEquipment2022-06-0108063677core:AfterOneYear2022-06-0108063677core:WithinOneYear2022-06-0108063677core:ListedExchangeTraded2022-06-0108063677core:UnlistedNon-exchangeTraded2022-06-0108063677core:ShareCapital2022-06-0108063677core:SharePremium2022-06-0108063677core:RevaluationReserve2022-06-0108063677core:OtherReservesSubtotal2022-06-0108063677core:RetainedEarningsAccumulatedLosses2022-06-0108063677core:AfterOneYear2023-06-012024-05-3108063677core:WithinOneYear2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3108063677core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3108063677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3108063677core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3108063677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3108063677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3108063677bus:Director12023-06-012024-05-3108063677bus:Director22023-06-012024-05-3108063677core:FurnitureFittingsToolsEquipment2023-05-3108063677core:FurnitureFittingsToolsEquipment2024-05-3108063677core:FurnitureFittingsToolsEquipment2023-06-012024-05-31

Lords Healthcare Ltd

Registered Number
08063677
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

Lords Healthcare Ltd
Company Information
for the year from 1 June 2023 to 31 May 2024

Directors

Mr Z Z Musaji
Mr A K Sharma

Registered Address

Lords Pharmacy
Unit 61 The Guineas Centre
Newmarket
CB8 8EQ

Registered Number

08063677 (England and Wales)
Lords Healthcare Ltd
Balance Sheet as at
31 May 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets394,674118,343
94,674118,343
Current assets
Stocks151,671126,917
Debtors4337,280329,778
Cash at bank and on hand345,487636,265
834,4381,092,960
Creditors amounts falling due within one year5(516,071)(762,566)
Net current assets (liabilities)318,367330,394
Total assets less current liabilities413,041448,737
Net assets413,041448,737
Capital and reserves
Called up share capital22
Profit and loss account413,039448,735
Shareholders' funds413,041448,737
The financial statements were approved and authorised for issue by the Board of Directors on 13 January 2025, and are signed on its behalf by:
Mr A K Sharma
Director
Registered Company No. 08063677
Lords Healthcare Ltd
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Taxation for the year comprises current. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery20
Fixtures and fittings20
Office Equipment20
Stocks and work in progress
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
2.Average number of employees

20242023
Average number of employees during the year2017
3.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 June 2319,722236,3706,148262,240
At 31 May 2419,722236,3706,148262,240
Depreciation and impairment
At 01 June 238,796130,9394,162143,897
Charge for year2,18521,08639823,669
At 31 May 2410,981152,0254,560167,566
Net book value
At 31 May 248,74184,3451,58894,674
At 31 May 2310,926105,4311,986118,343
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables249,225248,961
Other debtors76,63068,728
Prepayments and accrued income11,42512,089
Total337,280329,778
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables412,459374,711
Amounts owed to related parties-274,637
Taxation and social security68,32881,624
Other creditors35,28431,594
Total516,071762,566
6.Related party transactions
Amounts owed to related parties is Nil (2023: £274,637) this relates to MMOR Medicines Ltd which is the holding company. Included in other creditors is the directors' current account balance of £3,024 (2023: £2,400) which relates to both the directors.